G

Grey Sky Venture Partners

2 employees

Grey Sky Venture Partners is a new early-stage investment firm that invests in the areas of healthcare sectors.

Investor insights

Sectors invested in

Biotechnology5
Product Research4
Health Care4
Machine Learning3
Medical3
Neuroscience3
Artificial Intelligence3
Therapeutics2
Information Technology2
Speech Recognition2
Health Diagnostics2
Market Research2
Alzheimer's and aphasia detection2
machine learning2
artificial intelligence2
speech processing2
reconstructive surgery2
skin flaps2
critical limb ischemia2
vascular disease2

Funding rounds participated in

$4.4M sweet spot round size

Most of their 10 investments are in rounds between $2.7M and $7M

Investor type

Venture Capital

Basic info

Industry

investment management

Sectors

Health Care

Date founded

2016

Investments made

I

Inflammatix, Inc. raised $32M on January 10, 2020

Investors: Northpond Ventures, Khosla Ventures and Grey Sky Venture Partners

W

Winterlight Labs raised $4.2M on November 18, 2019

Investors: Hikma Ventures, Pacific Health Ventures and Grey Sky Venture Partners

A

AmacaThera raised $2.7M on October 3, 2019

Investors: Lumira Ventures, Viva BioInnovator, Sprout BioVentures and Grey Sky Venture Partners

A

Altoida, Inc. raised $6.3M on May 23, 2019

Investors: FYRFLY Venture Partners, VI Partners AG, M Ventures, Alpana Ventures SA and Grey Sky Venture Partners

M

Modulim raised $7M on January 23, 2019

Investors: Pangaea Ventures, Fresenius Medical Care and Grey Sky Venture Partners

H

HepaTx Corporation raised $2.1M on August 20, 2018

Investors: Y Combinator and Grey Sky Venture Partners

B

Biolinq raised $10M on November 27, 2017

Investors: Three Leaf Ventures, LifeSci Venture Partners, Hikma Ventures, M Ventures and Grey Sky Venture Partners

M

Modulim raised $2.9M on November 16, 2017

Investors: Fresenius Medical Care and Grey Sky Venture Partners

W

Winterlight Labs raised $1M on August 25, 2017

Investors: Grey Sky Venture Partners

S

Sonavex, Inc. raised $4.5M on April 24, 2017

Investors: Dingman Center for Entrepreneurship, Abell Foundation Inc, NewGen Venture Partners, MBX Capital, FundRx, CRCM Ventures and Grey Sky Venture Partners

FAQ